- MUC1-specific targeting immunotherapy with bispecific antibodies: inhibition of xenografted human bile duct carcinoma growth. Katayose, Y., Kudo, T., Suzuki, M., Shinoda, M., Saijyo, S., Sakurai, N., Saeki, H., Fukuhara, K., Imai, K., Matsuno, S. Cancer Res. (1996)